(3aS,9aS,9bS)-2-(6,7-difluoroquinazolin-4-yl)-1,3,3a,4,6,7,8,9,9a,9b-decahydropyrrolo[3,4-a]indolizine
C18H20F2N4 — CID 129425843
Data last refreshed: (MolForge compound catalog, from PubChem)
About (3aS,9aS,9bS)-2-(6,7-difluoroquinazolin-4-yl)-1,3,3a,4,6,7,8,9,9a,9b-decahydropyrrolo[3,4-a]indolizine
(3aS,9aS,9bS)-2-(6,7-difluoroquinazolin-4-yl)-1,3,3a,4,6,7,8,9,9a,9b-decahydropyrrolo[3,4-a]indolizine (PubChem CID 129425843) has the molecular formula C18H20F2N4 and a molecular weight of 330.38 g/mol. Its IUPAC name is (3aS,9aS,9bS)-2-(6,7-difluoroquinazolin-4-yl)-1,3,3a,4,6,7,8,9,9a,9b-decahydropyrrolo[3,4-a]indolizine.
Molecular Properties
| Compound Name | (3aS,9aS,9bS)-2-(6,7-difluoroquinazolin-4-yl)-1,3,3a,4,6,7,8,9,9a,9b-decahydropyrrolo[3,4-a]indolizine |
|---|---|
| PubChem CID | 129425843 |
| Molecular Formula | C18H20F2N4 |
| Molecular Weight | 330.38 g/mol |
| Exact Mass | 330.17 |
| IUPAC Name | (3aS,9aS,9bS)-2-(6,7-difluoroquinazolin-4-yl)-1,3,3a,4,6,7,8,9,9a,9b-decahydropyrrolo[3,4-a]indolizine |
| SMILES | Fc1cc2ncnc(N3C[C@@H]4CN5CCCC[C@H]5[C@@H]4C3)c2cc1F |
| InChI | InChI=1S/C18H20F2N4/c19-14-5-12-16(6-15(14)20)21-10-22-18(12)24-8-11-7-23-4-2-1-3-17(23)13(11)9-24/h5-6,10-11,13,17H,1-4,7-9H2/t11-,13+,17-/m0/s1 |
| InChIKey | ZEEMXXMUYPRTBB-PPHDSNJXSA-N |
| XLogP | 2.83 |
| TPSA | 32.26 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 1 |
| Heavy Atoms | 24 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 330.38 |
| LogP ≤ 5 | 2.83 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 129425843 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.